Larimar Therapeutics Inc (LRMR)
7.38
-0.05
(-0.67%)
USD |
NASDAQ |
May 17, 16:00
7.38
0.00 (0.00%)
After-Hours: 20:00
Larimar Therapeutics 1 Year Total Returns (Daily): 100.0% for May 17, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 17, 2024 | 100.0% |
| May 16, 2024 | 103.6% |
| May 15, 2024 | 119.2% |
| May 14, 2024 | 55.73% |
| May 13, 2024 | 44.66% |
| May 10, 2024 | 39.06% |
| May 09, 2024 | 54.42% |
| May 08, 2024 | 64.32% |
| May 07, 2024 | 71.88% |
| May 06, 2024 | 74.21% |
| May 03, 2024 | 68.80% |
| May 02, 2024 | 67.25% |
| May 01, 2024 | 58.06% |
| April 30, 2024 | 45.67% |
| April 29, 2024 | 39.75% |
| April 26, 2024 | 42.48% |
| April 25, 2024 | 40.35% |
| April 24, 2024 | 43.56% |
| April 23, 2024 | 43.56% |
| April 22, 2024 | 42.22% |
| April 19, 2024 | 32.72% |
| April 18, 2024 | 35.74% |
| April 17, 2024 | 51.61% |
| April 16, 2024 | 59.82% |
| April 15, 2024 | 61.15% |
| Date | Value |
|---|---|
| April 12, 2024 | 53.64% |
| April 11, 2024 | 58.68% |
| April 10, 2024 | 53.71% |
| April 09, 2024 | 57.49% |
| April 08, 2024 | 61.52% |
| April 05, 2024 | 70.25% |
| April 04, 2024 | 66.36% |
| April 03, 2024 | 69.67% |
| April 02, 2024 | 62.47% |
| April 01, 2024 | 64.68% |
| March 28, 2024 | 72.50% |
| March 27, 2024 | 63.26% |
| March 26, 2024 | 60.36% |
| March 25, 2024 | 68.82% |
| March 22, 2024 | 86.41% |
| March 21, 2024 | 80.21% |
| March 20, 2024 | 76.60% |
| March 19, 2024 | 59.67% |
| March 18, 2024 | 55.20% |
| March 15, 2024 | 50.26% |
| March 14, 2024 | 47.37% |
| March 13, 2024 | 62.30% |
| March 12, 2024 | 59.17% |
| March 11, 2024 | 56.62% |
| March 08, 2024 | 67.76% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-94.06%
Minimum
Sep 26 2019
160.7%
Maximum
Dec 07 2020
-15.90%
Average
-25.27%
Median
Oct 05 2021
1 Year Total Returns (Daily) Benchmarks
| ACADIA Pharmaceuticals Inc | -34.79% |
| Mersana Therapeutics Inc | -64.77% |
| Equillium Inc | 169.0% |
| Monopar Therapeutics Inc | -29.48% |
| Vera Therapeutics Inc | 445.3% |